Author/Creator: Clifton, Guy T - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Clifton, Guy T

1. Adjuvant HER2/neu peptide cancer vaccines in breast cancer. (November 2015)

Authors:: Clifton, Guy T; Mittendorf, Elizabeth A; Peoples, George E
Journal:: Immunotherapy
Issue:: Volume 7:Number 11(2015:Nov.)
Page Start:: 1159
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Comparison of different HER2/neu vaccines in adjuvant breast cancer trials: implications for dosing of peptide vaccines. (February 2011)

Authors:: Benavides, Linda C; Sears, Alan K; Gates, Jeremy D; Clifton, Guy T; Clive, Kevin S; Carmichael, Mark G; Holmes, Jarrod P; Mittendorf, Elizabeth A; Ponniah, Sathibalan; Peoples, George E
Journal:: Expert review of vaccines
Issue:: Volume 10:Number 2(2011)
Page Start:: 201
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Immunotherapy as a partner for HER2-directed therapies. Issue 7 (3rd July 2021)

Authors:: Clifton, Guy T; Peoples, and George E
Journal:: Expert review of anticancer therapy
Issue:: Volume 21:Issue 7(2021)
Page Start:: 739
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Preliminary results for the phase 1 trial of a folate receptor alpha adjuvant cancer vaccine in ovarian and endometrial cancer patients. (7th November 2013)

Authors:: Berry, John S; Schneble, Erika J; Trappey, Alfred F; Vreeland, Timothy J; Clifton, Guy T; Hale, Diane F; Sears, Alan K; Ponniah, Sathibalan; Mittendorf, Elizabeth A; Peoples, George E
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 1(2013)Supplement 1
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. The development and use of the E75 (HER2 369–377) peptide vaccine. (June 2016)

Authors:: Clifton, Guy T; Peoples, George E; Mittendorf, Elizabeth A
Journal:: Future oncology
Issue:: Volume 12:Number 11(2016)
Page Start:: 1321
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. The HER2 peptide nelipepimut-S (E75) vaccine (NeuVax™) in breast cancer patients at risk for recurrence: correlation of immunologic data with clinical response. (May 2014)

Authors:: Schneble, Erika J; Berry, John S; Trappey, Francois A; Clifton, Guy T; Ponniah, Sathibalan; Mittendorf, Elizabeth; Peoples, George E
Journal:: Immunotherapy
Issue:: Volume 6:Number 5(2014:May)
Page Start:: 519
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccine. (23rd February 2018)

Authors:: Hardin, Mark O; Vreeland, Timothy J; Clifton, Guy T; Hale, Diane F; Herbert, Garth S; Greene, Julia M; Jackson, Doreen O; Berry, John E; Nichols, Pauline; Yin, Sook; Yu, Xianzhong; Wagner, Thomas E; Peoples, George E
Journal:: Immunotherapy
Issue:: Volume 10:Number 5(2018)
Page Start:: 373
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Vaccine-specific T-cell proliferation in response to a dual peptide cancer vaccine in breast and ovarian cancer patients. (7th November 2013)

Authors:: Schneble, Erika J; Berry, John S; Trappey, Alfred F; Vreeland, Timothy J; Hale, Diane F; Sears, Alan K; Clifton, Guy T; Ponniah, Sathibalan; Shumway, Nathan M; Mittendorf, Elizabeth A; Peoples, George E
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 1(2013)Supplement 1
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗